Metallo-b-lactamase (MBL) producers have been reported among the various Acinetobacter species worldwide. In this study, the epidemiology and molecular characteristics of carbapenemase-encoding genes and mobile elements were studied to analyse the regional dissemination of MBL genes in Acinetobacter species. From January 2001 to December 2006, 48 Acinetobacter isolates harbouring MBL genes identified from five hospitals in Kyoto and Shiga Prefecture, Japan were collected and analysed. The partial rpoB gene or the 16S-23S ribosomal RNA intergenic spacer region was sequenced to obtain a species-level identification. Molecular typing using pulsedfield gel electrophoresis (PFGE) and multilocus sequence typing (MLST) was performed. Twenty-five Acinetobacter pittii isolates were divided into eight PFGE types and five sequence types (STs) using MLST. Nine Acinetobacter bereziniae isolates belonged to five PFGE types. Five Acinetobacter nosocomialis isolates were divided into two PFGE types and two STs. Three unclassified Acinetobacter species isolates were divided into two PFGE types. Eighteen of the 25 A. pittii isolates belonged to ST119 and were identified from four hospitals. The bla IMP-19 gene was detected in 41 of 48 isolates, including all of the A. pittii ST119 isolates. The bla IMP-1 and bla IMP-11 genes were detected in four and three isolates, respectively. The MBL genes were all embedded within a class 1 integron as a gene cassette array: bla IMP-19 -aac(6¢)-31-bla OXA-21 -aadA1, catB8-like/aacA4-bla IMP-1 and bla IMP-11 . This study is the first report demonstrating the regional dissemination of MBL-producing Acinetobacter species. A. pittii ST119 harbouring bla IMP-19 was widely spread throughout the Kyoto-Shiga region.
Introduction
Over the past two decades, the number of carbapenem-resistant Acinetobacter species isolates has dramatically increased, and these organisms have been disseminated worldwide. Metallo-b-lactamases (MBLs) and carbapenem-hydrolysing class D b-lactamases (CHDLs) are common contributors to carbapenem resistance [1] . MBL genes are typically embedded in integrons that accumulate antimicrobial resistance gene cassettes that are associated with the intra-and interspecies transfer of these resistance genes. Insertion sequence (IS)
In a previous study, we identified the dissemination of bla , which is located in a class 1 integron in various Acinetobacter species, including A. baumannii, A. pittii, Acinetobacter johnsonii and A. junii [10] . However, this study was only performed at a single institute, and the regional dissemination of MBL genes among Acinetobacter species has not been studied extensively. Therefore, the aim of this study was to analyse the regional epidemiology of MBL genes and their genetic environments among Acinetobacter species.
Materials and Methods

Bacterial isolates and MBL screening
From January 2001 to December 2006, a total of 1713 Acinetobacter species clinical isolates were identified from five hospitals, including three teaching university hospitals (A, B and E) and two city hospitals (C and D) in Kyoto and Shiga Prefecture, Japan. Three hospitals (A, B and C) were located in Kyoto, and two hospitals (D and E) were located in Shiga. The isolates were primarily identified as Acinetobacter species using the VITEK2 system (Sysmex-bioMérieux, Marcy l'Etoile, France) or the MicroScan system (Siemens Healthcare Diagnostics, Tokyo, Japan) in each hospital. Eighty-two of 1713 isolates with resistance to carbapenems or ceftazidime were detected using an automated system through phenotypic MBL screening. A phenotypic MBL screening test was performed using three disks (two Kirby-Bauer disks containing 30 lg of ceftazidime and one disk containing 3 mg of sodium mercaptoacetic acid (Eiken Chemical, Tokyo, Japan)), as previously described [11] . A ‡5 mm difference in the inhibition zone between the disks was considered a positive result for the detection of MBL. Fifty-four MBL-positive isolates of Acinetobacter were sent to Kyoto University Hospital for further analysis. Only one MBL-positive isolate per patient was included in this study. PCR screening was performed for the MBL genes (bla IMP , bla VIM and bla NDM-1 ) [10] . A total of 48 of the 54 Acinetobacter isolates were positive for MBL genes and were included in this study.
Species-level identification
Species identification was performed through sequencing of the partial rpoB gene (zone 1 between positions 2916 and 3267, 352 bp), as previously described [12, 13] . The nucleotide sequence homology was searched using the BLAST program (http://www.ncbi.nlm.nih.gov/BLAST). For isolates of the non-Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) complex, the sequences were compared with the reference sequences of Acinetobacter strains using the neighbour-joining method of the CLUSTAL X program [13] . The intergenic spacer region of 16S-23S ribosomal RNA was sequenced to identify the ACB complex [14] .
Molecular typing
Molecular typing was performed using pulsed-field gel electrophoresis (PFGE) with the GenePath system (Bio-Rad, Tokyo, Japan) and the restriction enzyme ApaI (New England BioLabs, Tokyo, Japan), as previously described [15] . The pattern analysis was conducted using GelCompar II v.4.062 software (Applied Maths, Sint-Martens-Latem, Belgium) with the unweighted-pair group method based on Dice coefficients and a cut-off of 80% similarity. Multilocus sequence typing (MLST) was also performed on the ACB complex using the Pasteur Institute scheme, and the results were analysed according to the Institut Pasteur MLST Database (http://www.pasteur.fr/recherche/genopole/PF8/mlst/Abaumannii.html) [16] .
Antimicrobial susceptibility testing
Antimicrobial susceptibility was determined using the broth microdilution method with commercially manufactured plates (Eiken Chemical) according to the 2012 CLSI guidelines and breakpoint criteria [17, 18] .
PCR amplification of carbapenemase-encoding genes, integrase genes and ISs PCR screening was performed for the carbapenemase-encoding genes and mobile genetic elements, including the CHDL genes (bla OXA-23-like , bla OXA-24-like , bla OXA-51-like and bla OXA-58-like ), integrase genes (intI1, intI2 and intI3) and IS element genes (ISAba1, ISAba2 and ISAba3), in addition to MBL genes, as previously described [10] .
Analysis of a class 1 integron carrying MBL genes and the genetic environment of CHDL genes For the detection of class 1 integron gene cassettes, PCR amplification (integron PCR) was performed with primers directed toward the 5¢-conserved segments (CSs) and 3¢-CS using PrimeSTAR TM HS DNA polymerase (TaKaRa Bio, Otsu, Japan) (Fig. 1) . The PCR procedures, cloning and sequence analysis of class 1 integron cassettes have been previously described [10] . For analysis of class 1 integrons carrying bla IMP-19 , cloning and sequencing were conducted for five clinical isolates and other strains harbouring bla IMP-19 using PCR mapping with the newly designed primer sets ( Fig. 1 ) [19] . Cloning and sequencing were also performed to identify the genetic arrays of class 1 integrons carrying bla IMP-1 and bla IMP-11 . To determine the genetic structures of the regions that flank the CHDL genes, a PCR analysis was performed using a series of previously described primers [20] . The primers used in the analysis of the genetic environment are shown in Table S1 .
Nucleotide sequence accession numbers
The nucleotide sequences of the integron gene cassettes that are newly reported in this paper have been submitted to the DNA Data Bank of Japan (DDBJ) and have been assigned the accession numbers AB713931, AB713932, AB713933, AB713952, AB713953 and AB713954.
Results and Discussion
Bacterial isolates and species identification
For this study, 48 clinical isolates of the Acinetobacter species that harboured the MBL gene were identified in the Kyoto-Shiga region. Twenty-five isolates were identified as A. pittii, nine isolates were identified as A. bereziniae, five isolates were identified as A. nosocomialis, and three isolates were unclassified Acinetobacter species. Single isolates of A. baumannii, Acinetobacter guillouiae (formerly Acinetobacter genomic species 11), Acinetobacter genomic species 15TU, Acinetobacter genomic species 16, A. junii and Acinetobacter ursingii were also identified. Fig. 2 illustrates the phylogenetic relationships between non-ACB complex isolates and Acinetobacter reference strains. A total of three Acinetobacter species isolates exhibited c. 96% identity to the rpoB gene in Acinetobacter gyllenbergii and belonged to the same species with high bootstrap values in the phylogenetic tree. However, these three isolates had a low bootstrap value (49.2%) for the corresponding branch of A. gyllenbergii. Therefore, we defined these isolates as 'unclassified' Acinetobacter species. The presence of unclassified species has been previously reported for the identification of Acinetobacter species using the partial rpoB gene sequence [13] . A. pittii isolates were identified from four hospitals (A, B, D and E),
A. bereziniae isolates were identified from three hospitals (A, B and C), A. nosocomialis isolates were identified from three hospitals (A, B and D) and unclassified Acinetobacter species were identified from two hospitals (A and B) ( Table 1 ). The origins of A. pittii, A. bereziniae, A. nosocomialis and unclassified Acinetobacter species isolates are shown in Fig. 3 . The origins of other isolates were obtained as follows: one A. baumannii (strain A12) was recovered from a nasopharyngeal swab; one A. guillouiae isolate (A13) was recovered from bile; single isolates of A. genomic species 16 (A5) and A. genomic species 15TU (A9) were recovered from ascites; a single A. junii isolate (E7) was recovered from sputum; and a single A. ursingii isolate (A7) was recovered from blood. The genus Acinetobacter currently comprises 27 validly named species and several other genomic species with provisional designations [21] [22] [23] . Using PCR-based species-level identification [12, 14] , we identified Acinetobacter species harbouring MBL genes that had not previously been reported (e.g. A. guillouiae, genomic species 15TU and A. ursingii). These identification and molecular typing methods are necessary for developing a detailed epidemiology of MBL genes among non-A. baumannii Acinetobacter species. Fig. 3 shows the results of molecular typing using PFGE and MLST. The 25 A. pittii isolates were divided into eight PFGE types and five sequence types (STs) using MLST (ST63, ST64, ST93, ST119 and ST121) (Fig. 3a) . ST119 was identified in closely related A. pittii isolates from four hospitals (A, B, D and E) ( Table 1 ). The A. pittii non-ST119 isolates were identified from two hospitals (A and B), but only one clonal PFGE type was identified in the ST63 isolates. The other isolates were sporadically identified (Fig. 3a) . The nine A. bereziniae isolates were primarily identified from two hospitals (A and B) and could be divided into five PFGE types; the PFGE analysis revealed that five of the nine isolates were closely related (Fig. 3b) . The five A. nosocomialis isolates were divided into two PFGE types and two STs (ST68 and ST71) (Fig. 3c) . The three unclassified Acinetobacter species isolates were divided into two PFGE types (Fig. 3d) . PFGE was not performed on the other Acinetobacter species because only one isolate of each species was positive for the MBL gene. An A. baumannii isolate belonging to ST120 was not related to European clones I, II or III. The molecular epidemiologies of the Acinetobacter isolates harbouring MBL genes are lacking. Although the molecular epidemiologies of A. pittii are currently insufficient for comparison with A. baumannii, the Pasteur Institute MLST scheme might be more applicable than the Bartual scheme for the number of sequence types submitted (http://pubmlst.org/ abaumannii). Thus, we conducted MLST using the Pasteur Institute scheme.
Molecular typing
Antimicrobial susceptibility
The antimicrobial susceptibility profiles are shown in Table 2 . None of the isolates were susceptible to imipenem. However, three isolates of A. pittii ST119 and one isolate of A. baumannii were susceptible to meropenem. Most of the isolates were susceptible to minocycline, colistin and ampicillin-sulbactam. However, ampicillin-sulbactam and colistin exhibited lower susceptibility rates against A. bereziniae, A. nosocomialis and unclassified Acinetobacter species than against other Acinetobacter isolates. In particular, all three of the unclassified Acinetobacter species isolates were resistant to colistin. The aminoglycosides had lower susceptibility rates against A. pittii non-ST119 and A. nosocomialis species than against other Acinetobacter isolates.
Carbapenemase-encoding genes and the genetic environment All of the isolates harboured the class 1 integrase gene (intI1). CHDL genes primarily contribute to carbapenem non-susceptibility among Acinetobacter species [2, 24] . Even in Japan, a recent study showed that 94.5% of the carbapenem-resistant Acinetobacter isolates harboured CHDL genes, and only one A. pittii isolate harboured an IMP-type MBL gene [25] . However, in another study conducted in Asia, A. pittii was reported to harbour MBL genes, including bla IMP-1, -4, and -8 and bla VIM-2 [6, 7, 9] .
All of the MBL genes detected in this study were embedded in a class 1 integron. The bla IMP-19 gene was identified in a gene cassette array of bla IMP-19 -aac(6¢)-31-bla OXA-21 -aadA1, the bla IMP-1 gene was in an array of catB8-like/aacA4-bla IMP-1 , and bla IMP-11 was the only component of another gene cassette array (Fig. 1) . The same class 1 integron carrying bla was detected in various Acinetobacter species. While this finding was reported in our previous study, the identification of this integron in A. nosocomialis, A. bereziniae and A. guillouiae was a recent discovery. These findings provide strong evidence for the inter-and intraspecies dissemination of this class 1 integron among Acinetobacter species. In contrast, no evidence of the intraspecies dissemination of a class 1 integron carrying bla IMP-1 and bla IMP-11 was demonstrated, although the regional spread and interspecies dissemination of these two MBL genes was detected.
One isolate of A. baumannii ST120 harboured bla OXA-51-like and ISAba2 in addition to bla IMP-19 , but ISAba2 was not identified up-or downstream of bla OXA-51-like . ISAba3 flanked both sides of the bla OXA-58 gene, which was detected in the single isolate of A. pittii ST93 harbouring bla IMP-1 and three isolates (one isolate of A. pittii ST63 and two isolates of unclassified Acinetobacter species) harbouring bla IMP-11 (Fig. 3) . Other CHDL genes were not detected in the isolates included in this study. This finding is consistent with previous reports [7, 26] . Among the non-A. baumannii Acinetobacter species, two ISAba3 genes flanked the bla OXA-58-like gene, which is widely disseminated in Eastern Asian countries.
Notably, there was one major limitation of this study. We screened the Acinetobacter isolates harbouring MBL genes collected between 2001 and 2006 and could not directly determine whether the MBL genes described in this study 100  95  90  85  80  75   100  90  80  70  60  50  40  30   100  90  80  70  60  50  40  30   100  90  80  70  60  50  40 were still disseminated among Acinetobacter species. From 2007 to 2010, 10 Acinetobacter isolates harboured exactly the same class 1 integron containing bla IMP-19 as identified in our institute [10] . These data suggest the possibility of continued integron-borne MBL gene dissemination among the species in this region.
In conclusion, this is the first report that demonstrates the regional and molecular epidemiology of Acinetobacter species harbouring integron-borne MBL genes and provides details of their species-level identification. The IMP-type MBL genes were detected in various Acinetobacter species. In particular, the bla IMP-19 gene was predominantly identified among many Acinetobacter species, particularly A. pittii ST119. The CHDL genes were indeed major contributors to carbapenem-non-susceptibility worldwide; however, the continued investigation of MBL genes in Acinetobacter species is required.
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